260 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

ArchiMed Acquisitions

ArchiMed has acquired 17 companies and its latest acquisition was Pyxant Labs, Inc. on Jul 2021

Unlock 14 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Pyxant Labs, Inc.

Jul 2021

Source »
undisclosed
Pyxant is a Colorado-based biotechnology firm that offers bioanalytical contract research services for the healthcare industry.
ImaBiotech

Jul 2021

Source »
undisclosed
ImaBiotech is a France-based biotechnology firm that offers services such as biodistribution, formulation screening, and pathology for oncology and dermatology diseases.
Stragen Pharma SA

Jun 2021

Source »
undisclosed
Stragen is a Switzerland-based pharmaceutical company that develops and commercializes generic drugs for treating patients with life-threatening conditions.
ZYTO Corporation

Jan 2021

Source »
undisclosed
ZYTO develops and produces software and integrated hardware products for personal health and wellness market.
North American Science Associates, LLC

Sep 2020

Source »
undisclosed
NAMSA is an Ohio-based contract research organization that provides services such as product development, safety consulting, and clinical research for the medical industry.

Frequently Asked Questions about ArchiMed

  1. What companies did ArchiMed acquire?

    Companies acquired by ArchiMed include Pyxant, ImaBiotech and Stragen

  2. How many acquisitions does ArchiMed have?

    ArchiMed has acquired 17 companies including Pyxant, ImaBiotech and Stragen.

  1. How many acquisitions did ArchiMed make in 2021?

    In 2021 ArchiMed acquired 4 companies including Pyxant, ImaBiotech and Stragen.